Resolute Wealth Advisor’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$444 Buy
+124
New +$420 ﹤0.01% 476

Other funds holding RXRX

Resolute Wealth Advisor's RXRX Position: Q3 2026 in Review

Resolute Wealth Advisor opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 124 shares worth $444. The stake represents ﹤0.01% of the portfolio and ranks #476 among its holdings.

353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • Resolute Wealth Advisor held 124 shares of Recursion Pharmaceuticals worth $444 as of Q3 2026.
  • Recursion Pharmaceuticals was a new Resolute Wealth Advisor position in Q3 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Resolute Wealth Advisor's portfolio in Q3 2026, its #476 holding.
  • 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on Resolute Wealth Advisor's 13F filing for Q3 2026, filed 12 Nov 2026.